{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:26:34Z","timestamp":1770549994571,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NSF IGERT LifeChips","award":["DGE-0549479"],"award-info":[{"award-number":["DGE-0549479"]}]},{"name":"UCMEXUS"},{"name":"NIH NIAID","award":["R21096278"],"award-info":[{"award-number":["R21096278"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clim.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T16:54:14Z","timestamp":1376585654000},"page":"388-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"PB","title":["TSPAN33 is a novel marker of activated and malignant B cells"],"prefix":"10.1016","volume":"149","author":[{"given":"Van Phi","family":"Luu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hevezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Vences-Catalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Maravillas-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton Alexander","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Casali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Jakez-Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Vilches-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Flores-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"Santos-Argumedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Zlotnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2013.08.005_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2232","article-title":"Launching the T-cell-lineage developmental programme","volume":"8","author":"Rothenberg","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0008-8749(90)90200-B","article-title":"Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas","volume":"129","author":"Suda","year":"1990","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2013.08.005_bb0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/251550a0","article-title":"B-cell suppression of delayed hypersensitivity reactions","volume":"251","author":"Katz","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.08.005_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1742-7843.2009.00452.x","article-title":"Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis","volume":"106","author":"Korhonen","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.clim.2013.08.005_bb0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.clim.2013.08.005_bb0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1096\/fj.04-3552fje","article-title":"Effects of RNA degradation on gene expression analysis of human postmortem tissues","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2013.08.005_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10048-006-0032-6","article-title":"Gene expression analyses reveal molecular relationships among 20 regions of the human CNS","volume":"7","author":"Roth","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.clim.2013.08.005_bb0055","doi-asserted-by":"crossref","first-page":"e63949","DOI":"10.1371\/journal.pone.0063949","article-title":"Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins","author":"Gerber","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2013.08.005_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1096\/fasebj.11.6.9194523","article-title":"The tetraspanin superfamily: molecular facilitators","volume":"11","author":"Maecker","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2013.08.005_bb0070","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.172.5.2953","article-title":"A regulatory role for CD37 in T cell proliferation","volume":"172","author":"van Spriel","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0075","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1182\/blood-2006-09-046672","article-title":"Penumbra encodes a novel tetraspanin that is highly expressed in erythroid progenitors and promotes effective erythropoiesis","volume":"109","author":"Heikens","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.08.005_bb0080","doi-asserted-by":"crossref","first-page":"e40321","DOI":"10.1371\/journal.pone.0040321","article-title":"Gene expression commons: an open platform for absolute gene expression profiling","volume":"7","author":"Seita","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2013.08.005_bb0085","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nsmb.1884","article-title":"14-3-3 adaptor proteins recruit AID to 5\u2032-AGCT-3\u2032-rich switch regions for class switch recombination","volume":"17","author":"Xu","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.clim.2013.08.005_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and characterization of BALB\/c lymphoma lines with B cell properties","volume":"122","author":"Kim","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.08.005_bb0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2013.08.005_bb0105","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.4049\/jimmunol.1102903","article-title":"CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity","volume":"188","author":"Burkhardt","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0110","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.162.9.5327","article-title":"The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites","volume":"162","author":"Schaffer","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni.1725","article-title":"HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation","volume":"10","author":"Park","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0120","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.1004018","article-title":"Myosin 1c participates in B cell cytoskeleton rearrangements, is recruited to the immunologic synapse, and contributes to antigen presentation","volume":"187","author":"Maravillas-Montero","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","article-title":"B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma","volume":"20","author":"Breen","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.clim.2013.08.005_bb0130","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1158\/0008-5472.CAN-12-1639","article-title":"Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma","volume":"72","author":"De Roos","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2013.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.5858\/133.7.1121","article-title":"Diffuse large B-cell lymphoma\u2014more than a diffuse collection of large B cells: an entity in search of a meaningful classification","volume":"133","author":"Gurbuxani","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.clim.2013.08.005_bb0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1309\/AJCP3FEPX5BEEKGX","article-title":"Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system","volume":"137","author":"McGowan","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clim.2013.08.005_bb0150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.MP.0000019577.73786.64","article-title":"The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement","volume":"15","author":"Nakamura","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.clim.2013.08.005_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"Kuppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.clim.2013.08.005_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Perez-Galan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.08.005_bb0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/modpathol.2009.73","article-title":"Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"22","author":"Nyman","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.clim.2013.08.005_bb0170","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00277-012-1407-4","article-title":"Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL","volume":"91","author":"Suzuki","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.clim.2013.08.005_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar3433","article-title":"Mechanisms of B cell autoimmunity in SLE","volume":"13","author":"Dorner","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.08.005_bb0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2249.1993.tb06494.x","article-title":"B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation","volume":"93","author":"Spronk","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0185","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar2773","article-title":"Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort","volume":"11","author":"Gottenberg","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.08.005_bb0190","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2011-200975","article-title":"Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort","volume":"71","author":"Gottenberg","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2013.08.005_bb0195","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1172\/JCI25265","article-title":"BLyS and APRIL in rheumatoid arthritis","volume":"115","author":"Seyler","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2013.08.005_bb0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/08916934.2011.577128","article-title":"AID dysregulation in lupus-prone MRL\/Fas(lpr\/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc\/IgH loci translocations: modulation by HoxC4","volume":"44","author":"White","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2013.08.005_bb0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","article-title":"Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease","volume":"9","author":"Cohen","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08916930802629554","article-title":"Lupus-prone MRL\/faslpr\/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination","volume":"42","author":"Zan","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2013.08.005_bb0215","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.gene.6364286","article-title":"Genomic view of systemic autoimmunity in MRLlpr mice","volume":"7","author":"Liu","year":"2006","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2013.08.005_bb0220","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2013.08.005_bb0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1615\/CritRevImmunol.v32.i4.10","article-title":"Regulatory roles of the tumor necrosis factor receptor BCMA","volume":"32","author":"Coquery","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2013.08.005_bb0235","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.08.005_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.smim.2007.12.002","article-title":"Plasma cell development: from B-cell subsets to long-term survival niches","volume":"20","author":"Fairfax","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-3083.2008.02117.x","article-title":"Gene array analysis comparison between rat collagen-induced arthritis and human rheumatoid arthritis","volume":"68","author":"Soto","year":"2008","journal-title":"Scand. J. Immunol."},{"issue":"Suppl. 4","key":"10.1016\/j.clim.2013.08.005_bb0250","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1010","article-title":"Roles of B cells in rheumatoid arthritis","volume":"5","author":"Silverman","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.08.005_bb0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.autrev.2006.02.004","article-title":"Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy","volume":"5","author":"Martinez-Gamboa","year":"2006","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2013.08.005_bb0260","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar3906","article-title":"B-cell targeted therapeutics in clinical development","volume":"15","author":"Bluml","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.08.005_bb0265","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3899\/jrheum.111488","article-title":"Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion","volume":"40","author":"Vancsa","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2013.08.005_bb0270","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2013.08.005_bb0275","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1128\/MCB.02047-06","article-title":"Germinal center marker GL7 probes activation-dependent repression of N-glycolylneuraminic acid, a sialic acid species involved in the negative modulation of B-cell activation","volume":"27","author":"Naito","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2013.08.005_bb0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1746-1596-6-97","article-title":"Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas","volume":"6","author":"Goteri","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.clim.2013.08.005_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0609.1998.tb01009.x","article-title":"Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma","volume":"60","author":"Erlanson","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.clim.2013.08.005_bb0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrneph.2012.141","article-title":"B-cell depletion in the treatment of lupus nephritis","volume":"8","author":"Gregersen","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"Suppl. 5","key":"10.1016\/j.clim.2013.08.005_bb0295","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis","volume":"51","author":"Choy","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2013.08.005_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2013.08.005_bb0305","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2013.08.005_bb0310","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/ar2789","article-title":"Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis","volume":"11","author":"Rehnberg","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2013.08.005_bb0315","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BST0390553","article-title":"Tetraspanin CD151 as a target for antibody-based cancer immunotherapy","volume":"39","author":"Haeuw","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.clim.2013.08.005_bb0320","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.hoc.2009.01.009","article-title":"Diagnosis and management of acquired pure red cell aplasia","volume":"23","author":"Sawada","year":"2009","journal-title":"Hematol. Oncol. Clin North Am."},{"key":"10.1016\/j.clim.2013.08.005_bb0325","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.clim.2013.08.005_bb0330","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00002371-199605000-00003","article-title":"Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors","volume":"19","author":"Surfus","year":"1996","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"key":"10.1016\/j.clim.2013.08.005_bb0335","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1042\/BST0390512","article-title":"Tetraspanins in the humoral immune response","volume":"39","author":"van Spriel","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.clim.2013.08.005_bb0340","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.immuni.2012.11.019","article-title":"The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling","volume":"38","author":"Mattila","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2013.08.005_bb0345","doi-asserted-by":"crossref","first-page":"ra82","DOI":"10.1126\/scisignal.2003113","article-title":"The tetraspanin CD37 orchestrates the alpha(4)beta(1) integrin-Akt signaling axis and supports long-lived plasma cell survival","volume":"5","author":"van Spriel","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.clim.2013.08.005_bb0350","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/eji.201141438","article-title":"The role of tetraspanin CD63 in antigen presentation via MHC class II","volume":"41","author":"Petersen","year":"2011","journal-title":"Eur. J. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T15:23:13Z","timestamp":1715872993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661613002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1521661613002180"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2013.08.005","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TSPAN33 is a novel marker of activated and malignant B cells","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}